About 260 Mg Paclitaxel Injection IP
Utilise this potent 260 mg Paclitaxel Injection IP, housed in a lofty 43.4 ml glass vial for valorous chemotherapy interventions. Favored by favorable reviews in oncology settings, it features instant checkout for easy procurement by distributors, exporters, suppliers, and traders across India. As an IP grade prescription drug, the sterile, single-use vial is administered via intravenous drip infusion, exclusively in a hospital environment. Composed of Paclitaxel, polyoxyethylated castor oil, absolute alcohol, citric acid, and anhydrous salt, it requires dilution and is compatible with normal saline or dextrose. Protect below 25C and from light.
Extra Features and Application Areas
260 Mg Paclitaxel Injection IP stands out with its sterile, single-use vial and compatibility with both normal saline and dextrose. Designed to be diluted prior to administration, it functions as a potent chemotherapy agent for ovarian cancer, breast cancer, non-small cell lung cancer, and Kaposi's sarcoma. Healthcare professionals should strictly follow prescription guidelines, ensuring hospital-only administration. The clear, colorless to pale yellow solution maximizes reliability and safety during therapeutic use.
Supply Ability and Shipping Details
Shipped goods are processed promptly from India's major FOB ports upon receipt of a formal purchase order. We charge competitive rates for reliable delivery of 260 Mg Paclitaxel Injection IP, maintaining robust supply ability year-round. Standard orders are efficiently dispatched within a defined delivery time frame, supporting distributors, traders, and exporters to meet urgent pharmaceutical needs for hospitals and clinics. Each vial is packaged to ensure preservation and quality throughout transportation.
FAQ's of 260 Mg Paclitaxel Injection IP:
Q: How should 260 Mg Paclitaxel Injection IP be diluted before administration?
A: 260 Mg Paclitaxel Injection IP must be diluted with either normal saline or dextrose before intravenous drip infusion, as directed by a qualified healthcare professional in a hospital setting.
Q: What cancers can be treated using Paclitaxel Injection IP?
A: Paclitaxel Injection IP is indicated for chemotherapy in ovarian cancer, breast cancer, non-small cell lung cancer, and Kaposi's sarcoma, offering a versatile application in cancer management.
Q: When is Paclitaxel Injection IP prescribed?
A: This injection is prescribed when cancer patients require a potent chemotherapy agent, as determined by an oncologist or specialist, based on clinical assessment and treatment protocols.
Q: Where should 260 Mg Paclitaxel Injection IP be stored?
A: Store Paclitaxel Injection IP below 25C, protect it from light, and never freeze. Ensure storage is in accordance with hospital pharmacy guidelines to maintain efficacy and safety.
Q: What is the process for ordering and receiving Paclitaxel Injection IP?
A: Place a purchase order with the distributor, exporter, supplier, or trader in India. Goods are shipped through major FOB ports, and competitive charges apply, with reliable supply and delivery times.
Q: How does Paclitaxel Injection IP benefit patients undergoing chemotherapy?
A: Paclitaxel Injection IP delivers a potent and sterile formulation, targeting malignant cells in various cancers, and optimizes therapeutic outcomes when administered under professional supervision.